Skip to main navigation

Home

Pipeline +

Overview

Complement Mediated Diseases

Compassionate Use Policy

Our Science +

Overview

Resources

Patients and Clinicians

About Achillion +

Overview

Leadership

Board of Directors

Business Development

Investors & News +

Overview

Stock Information

Press Releases

Events & Presentations

Annual Reports

Financial Information

Corporate Governance

FAQs

Contact Us

Connect

Join Us +

Life at Achillion

Opportunities

Legal

Privacy

Cookies

Achillion Pharmaceuticals

About Us
Our Focus
Patients & Clinicians
- Patients & Clinicians
- Compassionate Use Policy
Investors & News
Careers
- Opportunities
- Life at Achillion
Connect

INVESTORS

Press Releases

Category:

Year:

Items per page

There are currently no news releases to display.

Pagination

First page
Previous page
…
Page 4
Page 5
Page 6
Current page 7

Displaying 61 - 62 of 62 results

Investor Relations

Investor Overview
Events & Presentations
Press Releases
Financial Reports
SEC Filings
Annuals and Proxies
Stock Information
Analyst Coverage
Corporate Governance
Investor FAQs
Contact Us

Shareholder Tools

Email Alerts
Downloads
RSS
Print
Share
Search

Facebook
Google
LinkedIn
Twitter
RSS

Search

Home

About Achillion

Our Focus

Patients and Clinicians

Investors & News

Careers

Connect

Achillion Pharmaceuticals, Inc.

1777 Sentry Parkway West

VEVA Building #14,

Suite 200

Blue Bell, Pennsylvania 19422

main +215-709-3040

Achillion has been acquired by Alexion Pharmaceuticals, Inc.

For more information, click here.